Reply to M.A.N. Şendur et al and J. Michels.

J Clin Oncol

David F. Penson, Vanderbilt University and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN; Andrew J. Armstrong, Duke University, Durham, NC; Raoul Concepcion, Urology Associates PC, Nashville, TN; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, Netherlands; and Celestia S. Higano, University of Washington, Seattle, WA.

Published: January 2017

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.9371DOI Listing

Publication Analysis

Top Keywords

reply man
4
man Şendur
4
Şendur michels
4
reply
1
Şendur
1
michels
1

Similar Publications

Article Synopsis
  • The study aimed to understand how patients with myasthenia gravis (MG) perceive their condition and identify potential improvements in treatment.
  • Patients over 12 months with the disease participated in an online survey, resulting in 246 completed responses.
  • Key findings highlighted participants' desires for better physical activity, reduced fatigue, and suggested treatment improvements, including fewer side effects and simpler medication regimens.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!